Greg has 20 years of distinguished experience in healthcare policy and research. As a recognized health policy leader, Greg spent almost a decade leading pharmaceutical and medical device policy in the areas of value-based healthcare and payment, real-world evidence development, and FDA regulatory science. Prior to joining Edwards, Greg was the Deputy Center Director at the Duke-Margolis Center for Health Policy and Clinical Professor at Duke’s Fuqua School of Business where he directed the Washington, DC office and led the Center’s biomedical innovation policy portfolio. Prior to that he was a Fellow and Managing Director in the Center for Health Policy at the Brookings Institution. In addition, he was the Vice President, Government and Academic Research, at HealthCore Inc., an Anthem Company, where he lead large observational research studies focused in health economics and outcomes research, real world evidence, and safety and epidemiology that leveraged administrative claims, electronic health record, and other real-world data sources.
Greg is currently the Editor-In-Chief of Therapeutic Innovation & Regulatory Science scientific journal has recently joined the Board of Directors for the Innovation and Value Initiative (IVI). Greg holds a PhD in Pharmaceutical Economics, Policy, and Outcomes from the University of Arizona, and an MPH in Biostatistics, MS in Pharmaceutical Administration and a BS in Pharmacy, all from The Ohio State University.
